Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eeabb570cbfa42bdc37ecdc5ef9f6392 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0038 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-07 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 |
filingDate |
2016-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49c5498dbb14e7f8b8764248b737b479 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1206a562544008cbdcc0b9ed95f97585 |
publicationDate |
2018-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20180002228-A |
titleOfInvention |
enhancer for radiotheraphy comprising Ac-SDKP originated from thymosin |
abstract |
The present invention relates to a radiotherapy efficacy enhancer, which comprises an Ac-SDKP peptide consisting of an amino acid sequence of SEQ ID NO: 1 in which an N-terminal is acetylated, as an active ingredient. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-3120794-A1 |
priorityDate |
2016-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |